| Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial N Bhandari, T Rongsen-Chandola, A Bavdekar, J John, K Antony, ... The Lancet 383 (9935), 2136-2143, 2014 | 314 | 2014 |
| Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life N Bhandari, T Rongsen-Chandola, A Bavdekar, J John, K Antony, ... Vaccine 32, A110-A116, 2014 | 110 | 2014 |
| A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants PS Kulkarni, S Desai, T Tewari, A Kawade, N Goyal, BS Garg, D Kumar, ... Vaccine 35 (45), 6228-6237, 2017 | 109 | 2017 |
| Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants MB Appaiahgari, R Glass, S Singh, S Taneja, T Rongsen-Chandola, ... Vaccine 32 (6), 651-656, 2014 | 86 | 2014 |
| Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in North Indian infants T Rongsen-Chandola, TA Strand, N Goyal, E Flem, SS Rathore, A Arya, ... Vaccine 32, A134-A139, 2014 | 81 | 2014 |
| A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial N Bhandari, P Sharma, S Taneja, T Kumar, T Rongsen-Chandola, ... Journal of Infectious Diseases 200 (3), 421-429, 2009 | 77 | 2009 |
| Low‐birthweight infants born to short‐stature mothers are at additional risk of stunting and poor growth velocity: Evidence from secondary data analyses B Sinha, S Taneja, R Chowdhury, S Mazumder, T Rongsen‐Chandola, ... Maternal & child nutrition 14 (1), e12504, 2018 | 74 | 2018 |
| Comparison of Japanese and Indian intestinal microbiota shows diet-dependent interaction between bacteria and fungi S Pareek, T Kurakawa, B Das, D Motooka, S Nakaya, ... npj Biofilms and Microbiomes 5 (1), 37, 2019 | 66 | 2019 |
| India Rotavirus Vaccine Group. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial N Bhandari, T Rongsen-Chandola, A Bavdekar, J John, K Antony, ... Lancet 383 (9935), 2136-43, 2014 | 61 | 2014 |
| Estimating the incidence of enteric fever in children in India: a multi-site, active fever surveillance of pediatric cohorts J John, A Bavdekar, T Rongsen-Chandola, S Dutta, G Kang BMC public health 18, 1-6, 2018 | 60 | 2018 |
| Effect of zinc supplementation on morbidity and growth in hospital-born, low-birth-weight infants S Taneja, N Bhandari, T Rongsen-Chandola, D Mahalanabis, O Fontaine, ... The American journal of clinical nutrition 90 (2), 385-391, 2009 | 50 | 2009 |
| ROTAVAC® does not interfere with the immune response to childhood vaccines in Indian infants: A randomized placebo controlled trial TR Chandola, S Taneja, N Goyal, K Antony, K Bhatia, D More, N Bhandari, ... Heliyon 3 (5), 2017 | 33 | 2017 |
| Diarrheal etiology and impact of coinfections on rotavirus vaccine efficacy estimates in a clinical trial of a monovalent human–bovine (116E) oral rotavirus vaccine, Rotavac, India I Praharaj, JA Platts-Mills, S Taneja, K Antony, K Yuhas, J Flores, I Cho, ... Clinical Infectious Diseases 69 (2), 243-250, 2019 | 32 | 2019 |
| Active surveillance for intussusception in a phase III efficacy trial of an oral monovalent rotavirus vaccine in India J John, A Kawade, T Rongsen-Chandola, A Bavdekar, N Bhandari, ... Vaccine 32, A104-A109, 2014 | 29 | 2014 |
| Implementation of the WHO Multicentre Growth Reference Study in India BMK Bhandari N, Taneja S, Rongsen T, Chetia J, Sharma P, Bahl R, Kashyap DK Food Nutr Bull 25 (1), S66-71, 2004 | 23 | 2004 |
| Burden of typhoid and paratyphoid fever in India J John, A Bavdekar, T Rongsen-Chandola, S Dutta, M Gupta, S Kanungo, ... New England Journal of Medicine 388 (16), 1491-1500, 2023 | 22 | 2023 |
| SII BRV-PV author group. A randomized phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants PS Kulkarni, S Desai, T Tewari, A Kawade, N Goyal, BS Garg, D Kumar, ... Vaccine 35 (45), 6228-6237, 2017 | 22 | 2017 |
| Estimating the impact of COVID-19 pandemic related lockdown on utilization of maternal and perinatal health services in an urban neighborhood in Delhi, India B Sinha, N Dudeja, S Mazumder, T Kumar, P Adhikary, N Roy, ... Frontiers in global women's health 3, 816969, 2022 | 18 | 2022 |
| Evaluation of Antimicrobial Susceptibility Profile in Salmonella Typhi and Salmonella Paratyphi A: Presenting the Current Scenario in India and Strategy for Future … B Veeraraghavan, AK Pragasam, P Ray, A Kapil, S Nagaraj, ... The Journal of Infectious Diseases 224 (Supplement_5), S502-S516, 2021 | 17 | 2021 |
| Mid upper arm circumference as a predictor of risk of mortality in children in a low resource setting in India S Taneja, T Rongsen-Chandola, SB Mohan, S Mazumder, N Bhandari, ... PLoS One 13 (6), e0197832, 2018 | 17 | 2018 |
